These two reports address the effects of varicella-zoster ... vaccine recipients than among placebo recipients (0.6% vs. 0.4%), for unknown reasons. The review authors recommend vaccine ...

recombinant zoster vaccine (RZV) and adjuvanted quadrivalent formulation (aIIV4), among older adults. "From a safety standpoint, this study supports the simultaneous administration of RZV and ...